NHS National Pharmaceuticals Transition 2022_2

Published date: 19 July 2022

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.

Closing: 23 August 2022, 1pm

Contract summary

Industry

Pharmaceutical products - 33600000

Location of contract

WA7 2ES

Value of contract

£58,707,389.63

Procurement reference

CF-0977000D0O000000rwimUAA1

Published date

19 July 2022

Closing date

23 August 2022

Closing time

1pm

Contract start date

1 December 2022

Contract end date

31 May 2024

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Description

Invitation to offer for NHS National Pharmaceuticals Transition 2022_2
Offer reference number: CM/PHG/22/5655
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.
Potential periods of call-offs under the framework agreement:

Transition:
CESW: 01/12/2022 to 30/09/2023 (10 months)
LSNE: 01/12/2022 to 31/05/2024 (18 months)
NWLN: 01/12/2022 to 31/05/2023 (6 months)

More information

Links

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IvjG/yEaNfC5Y6JwDSPjWoCRRiZ.HCBL80FgO_RTOO5WIyqQ
Document No. 05b - Selectt offer schedule instructions

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IvjF/B6uuKf5UqznqkGnp9W1GOrRAyer7ZV0qbTGoYGvaBw0
Document No. 06 - Form of offer

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivj2/YkgGZhKKh3HMeAv2.qk7J5doGJtRYTIpEdsm7wdBNJ0
Document No. 07a - Quality control technical sheet

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivje/cHqIuNUcp2PZUW6Z17qF85YJhES3UVQqZCd9ZFs1oVo
Document No. 00 - Read Me First Document

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivis/u4_DrX6okTHLwodKdhWtBHw2vSPX1WsTRKdZE32_U84
Document No. 08 - Confidential information schedule

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IvjZ/xVpEfJRGUjri3drUYVY71cmSaNcqLbr1XKKUfrp22GU
Document No. 01 - Invitation to offer covering letter

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IvjP/yrDUAf0S1YBEin_pG46sQ.Nf95rxSyHTwfUxW_PpMjI
Document No. 03 - Framework Agreement and Terms and Conditions

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Iviq/rYRrBntgVTzsywqejDFpoU7YZuUNlW8eaTBv1JP0P_o
Qualification Questionnaire - Transition 2022_2

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000IvjQ/yqwBlJKTpyFKBhYtXzgWysBAYKyhDfcPzKiWYCekqLE
Document No. 02 - Terms of offer

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivj4/qgajUgplVAri9bToYF9u6uf0TEPHe8PQkkDu.daZx3Q
Document No. 04 - Contract technical specification

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivj0/QeRR85j55pkxrCWvUQLvCMRNleepwbMxypEKgjOpGzE
Document No. 05a (i) Product listing and usage - Transition CM_PHG_22_5655_00

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivj3/7Ee5Trmm5oIfqSu8SeB4vCdvaFvF1gzseKwADZGLGC4
Document No. 07b - Guidance for performing a risk assessment of licensed medicines for the NHS

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivj1/frO_kGKP7ZsRleNjyWVG.TmWbqjikFdCuFr34ZMzyX4
Document No. 09 - Graphs

https://atamis-1928.cloudforce.com/sfc/p/0O000000rwim/a/8d000000Ivir/VS.kZqx3GQmsc9vSW5vfGqiCuf55ZUymhlEUIk6kGFY
Document No. 05a (ii) CM_PHG_22_5655 SELECTT Application

About the buyer

Contact name

David Ford

Address

2nd Floor Rutland House
Runcorn
WA7 2ES
UK

Email

david.ford1@nhs.net